Skip to main content

and
  1. No Access

    Article

    Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA study

    The integration of palliative care (PC) into oncological management is recommended well before the end of life. It improves quality of life and symptom control and reduces the aggressiveness of end-of-life car...

    Mathilde Lochmann, Magali Girodet, Johanna Despax in Supportive Care in Cancer (2024)

  2. Article

    Open Access

    Radiotherapy in bone sarcoma: the quest for better treatment option

    Bone sarcomas are rare tumors representing 0.2% of all cancers. While osteosarcoma and Ewing sarcoma mainly affect children and young adults, chondrosarcoma and chordoma have a preferential incidence in people...

    Marie-Anaïs Locquet, Mehdi Brahmi, Jean-Yves Blay, Aurélie Dutour in BMC Cancer (2023)

  3. No Access

    Article

    Prognostic factors of the synovial sarcoma of the extremities: imaging does matter

    Synovial sarcomas (SS) of the extremities are rare soft tissue sarcomas that are more common in young adults. We deciphered the imaging phenotype of SS with the aim to determine if imaging could provide an inc...

    Mickael Tordjman, Charles Honoré, Amandine Crombé, Amine Bouhamama in European Radiology (2023)

  4. No Access

    Article

    Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours

    Sarcomas are a heterogeneous group of malignancies that arise from cells of a mesenchymal origin. Surgery forms the mainstay of the treatment of most patients with localized sarcoma and might be followed or pr...

    Armelle Dufresne, Mehdi Brahmi, Marie Karanian in Nature Reviews Clinical Oncology (2018)

  5. Article

    Open Access

    Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

    Leiomyosarcoma (LMS) are 15% of adult sarcomas and remain seldom curable in metastatic phase. The TAM receptors and their ligands are overexpressed or activated in multiple malignancies, including LMS.

    Carmela Dantas-Barbosa, Tom Lesluyes, François Le Loarer in British Journal of Cancer (2017)

  6. Article

    Open Access

    KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome

    Tumor genotype plays a crucial role in clinical management of GIST. Whether genetic polymorphism of KIT may influence GIST patient outcome is unclear.

    Mehdi Brahmi, Laurent Alberti, Armelle Dufresne, Isabelle Ray-Coquard in BMC Cancer (2015)

  7. Article

    Open Access

    Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology

    Aggressive fibromatosis (AF) is a rare fibroblastic proliferative disease with a locally aggressive behavior and no distant metastasis, characterized by driver mutations in CTNNB1 or the APC gene. When progressiv...

    Armelle Dufresne, Laurent Alberti, Mehdi Brahmi, Sarah Kabani in BMC Cancer (2014)